Skip to main content
. 2018 Feb 20;25(1):632–643. doi: 10.1080/10717544.2018.1440444

Figure 2.

Figure 2.

In vivo tumor growth inhibition (A) and body weight changes (B) of mice bearing SKOV-3 ovarian cancer xenografts after PT treatment with PBS (Inline graphic), a placebo (Inline graphic), 2CIS1 (Inline graphic), 2DTX1 (Inline graphic), 2DTX1/CIS1 (Inline graphic), and P13L0.15O1.52D1C1 (Inline graphic) formulations (on Days 0, 4, and 8). Each point is shown as the mean ± SD (n = 5).